M Ventures — 2017 Investments
2 investments dated 2017 · listed companies and verified rows first · show all
Indi Molecular develops small-molecule oncology therapeutics based on protein-catalyzed capture agents (PCCs) created through click chemistry, a synthetic process developed in collaboration with Caltech.
BiotechDeep TechMedical DevicesCulver City, US
Leroy Hood(Director)Andreas Jurgeit(Director)James Heath(Director)Heather Agnew(Executive Officer)Albert Luderer(Executive Officer, Director)Douglas Fisher(Director)
BiotechLondon
Harrison Rickerby(Executive Officer, Director)
BoardJames Field(Executive Officer, Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.